Hippocratic AI Launches Beta Testing of First Generative AI for Healthcare

John­son & John­son beat in­vestors’ ex­pec­ta­tions de­spite its medtech unit un­der­per­form­ing, with ex­ecs point­ing to the Asia-Pa­cif­ic re­gion as a con­tin­ued source of strug­gle. …

While Demis Has­s­abis is best known for steer­ing Al­pha­bet’s re­search ef­forts in ar­ti­fi­cial in­tel­li­gence, the 47-year-old is si­mul­ta­ne­ous­ly lead­ing a se­cre­tive biotech start­up look­ing to

Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and middle-age adults, CDC advisors have not yet